TITLE:
      A Neurocognitive and Immunological Study of a New Formula for Healthy Infants
SUMMARY:
      To compare the neurocognitive and immunological development in infants fed a new infant
      formula with functional specific nutrients to infants consuming a standard infant formula.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Full-term newborns (>37 weeks and <41 weeks gestation)

          -  Adequate birth weight for his gestational age (between 3-97 percentiles)

          -  Inclusion age: from 0 to 2 months (60 days)

          -  Maximum 30 days of exclusive breastfeeding

          -  From 30 days on, exclusive or >70% infant formula

          -  Normal Apgar score: 7-10

          -  Umbilical pH â‰¥ of 7.10

          -  Availability to continue during the whole study period

          -  Informed consent signed ( parent/legal representative)

        Exclusion Criteria:

          -  Participating in other studies.

          -  Nervous system disorders (hydrocephalic, perinatal hypoxia, intraventricular
             hemorrhage, neonatal meningitis, septic shock, West Sd...).

          -  Gastrointestinal disorders (cow's milk protein allergy, lactose intolerance)

          -  Mother's disease history or during pregnancy: neurological and metabolic diseases,
             diabetes mellitus type 1, hypothyroidism, undernutrition, infections TORCH complex.

          -  Mothers receiving anxiolytic or antidepressant treatment during pregnancy or other
             potentially harmful drug treatments for infants' neurodevelopment.

          -  Infant currently participating in another clinical study

          -  Infant's family who in the investigators assessment cannot be expected to comply with
             the protocol.
